We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 02, 2022

The Graded Prognostic Assessment for SCLC and NSCLC Patients With Brain Metastases

International Journal of Radiation Oncology, Biology, Physics

 

Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Radiation Oncology, Biology, Physics
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors
Int. J. Radiat. Oncol. Biol. Phys 2022 Mar 21;[EPub Ahead of Print], PW Sperduto, B De, J Li, D Carpenter, J Kirkpatrick, M Milligan, HA Shih, T Kutuk, R Kotecha, H Higaki, M Otsuka, H Aoyama, M Bourgoin, D Roberge, S Dajani, S Sachdev, J Gainey, JM Buatti, W Breen, PD Brown, L Ni, S Braunstein, M Gallitto, TJC Wang, R Shanley, E Lou, J Shiao, LE Gaspar, S Tanabe, T Nakano, Y An, V Chiang, L Zeng, H Soliman, H Elhalawani, D Cagney, E Thomas, DH Boggs, MS Ahluwalia, MP Mehta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading